Mircera 75mcg injection contains active components such as Recombinant human erythropoietin alfa/epoetin alfa. It is a medication that belongs to a class of drugs called erythropoiesis-stimulating agents (ESAs). This medication treats anemia caused by chronic kidney disease (CKD), cancer chemotherapy, or HIV infection treatment with zidovudine. It also reduces the need for red blood cell transfusions in patients at high risk for blood loss due to planned surgery or other procedures.
Mircera 75mcg injection should not be used in patients with hypersensitivity to it or any of its components, uncontrolled hypertension, active thrombotic microangiopathy (TMA), pure red cell aplasia (PRCA), uncontrolled seizures, pregnancy, or lactation. It should also be used cautiously in patients with a history of blood clots, heart disease, stroke, kidney disease, liver disease, thalassemia, sickle cell anemia, myelodysplastic syndrome, leukemia, or cancer. It should only be used in children under 18 if the benefits outweigh the risks. Older adults taking this medication should be closely monitored for side effects. Before starting this medication, it is important to talk to your doctor about the risks and benefits of Mircera 75mcg injection.
Uses of Mircera 75mcg InjectionMircera 75mcg injection is used in the following:- Chronic kidney disease (CKD)
- Cancer chemotherapy
- HIV infection treatment with zidovudine
Therapeutic Effects of Mircera 75mcg Injection
Mircera 75mcg injection works by stimulating the bone marrow to produce more red blood cells. Red blood cells carry oxygen to the body's tissues, so increasing the number of red blood cells can help to treat anemia. Interaction of Mircera 75mcg Injection with other drugsInform the doctor about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Mircera 75mcg injection, reducing effectiveness by causing undesirable side effects.More Information about Mircera 75mcg Injection Should be stored at room temperature, between 2°C to 8°CKeep away from moisture, heat, and light.It should not be frozen.Keep away from children and pets.How to consume Mircera 75mcg InjectionMircera 75mcg injection Zyrop is given by subcutaneous injection, which means it is injected under the skin. The injection is usually given in the abdomen, thigh, or upper arm.Safety Advices for Mircera 75mcg Injection
Pregnancy
If you are pregnant or planning to become pregnant, talk to your doctor about the risks and benefits of Mircera 75mcg injection.
Breast Feeding
Mircera 75mcg injection's safety during breastfeeding is not well established. Consult a healthcare provider before using this medication while breastfeeding.
Lungs
If you have lung conditions, it is advisable to consult your healthcare provider before taking Mircera 75mcg injection.
Liver
Mircera 75mcg injection can cause liver problems in some people. If you have liver disease, you should talk to your doctor about the risks and benefits of taking this medication.
Alcohol
It is unsafe to take Mircera 75mcg injection with alcohol as it can increase your risk of side effects.
Driving
It is not safe to drive after receiving Mircera 75mcg injection as it can cause drowsiness and dizziness.
Side Effects of Mircera 75mcg InjectionMircera 75mcg injection causes some side effects like all medications, although not everyone will experience them. Serious
- Blood clots
- Stroke
- Heart attack
- Death
- High blood pressure
- Seizures
- Tumor growth
- Allergic reactions
- Kidney problems
- Liver problems
- Bone marrow problems
Common
- Headache
- Nausea
- Vomiting
- Diarrhea
- Muscle cramps
- Pain at the injection site
- Redness, swelling, or itching at the injection site
- Fatigue
- Dizziness
- Chills
- Fever
Word of AdviceTell your doctor about all your medical conditions, including high blood pressure, heart disease, stroke, kidney disease, liver disease, and cancer. Be careful if you have a history of blood clots. Monitor your blood pressure regularly while taking Mircera 75mcg injection. Get regular blood tests to monitor your red blood cell count and other blood levels. Do not self-inject this medication It should only be injected by a doctor or nurse. If you experience any side effects, tell your doctor immediately. Be careful when getting up from a sitting or lying position to avoid dizziness. Drink plenty of fluids to help prevent dehydration, which can increase your risk of blood clots. Talk to your doctor if you have any concerns about taking this medication.FAQs Q 1. What happens if I miss a dose of Mircera 75mcg injection?If you miss a Mircera 75mcg injection dose, contact your doctor as soon as possible. They will advise you on whether you need to take a double dose.
Q 2. How long does it take for Mircera 75mcg injection to work?It usually takes about 2-4 weeks for Mircera 75mcg injection to start working. However, the time it takes for the medication to work can vary depending on the patient's circumstances.
Q 3. Can I get Mircera 75mcg injection over the counter?No, Mircera 75mcg injection is a prescription medication and cannot be purchased over the counter.
Q 4. What is the dosage of Mircera 75mcg injection?The dosage of Mircera 75mcg injection will vary depending on your individual circumstances. Your doctor will determine the appropriate dosage for you.
Q 5. What are the most common side effects of Mircera 75mcg injection?The most common side effects of Mircera 75mcg injection are headache, nausea, vomiting, diarrhea, muscle cramps, pain at the injection site, and redness, swelling, or itching at the injection site. Serious side effects, such as blood clots, stroke, heart attack, and death, can also occur.
Q 6. What should I do if I have a leftover Mircera 75mcg injection?If you have a leftover Mircera 75mcg injection, you should return it to your doctor or pharmacist. Do not throw it away in the trash.
Fact Box of Mircera 75mcg InjectionMolecule name: Recombinant human erythropoietin alfa/epoetin alfa | Therapeutic class: Erythropoiesis-stimulating agents (ESAs) |
Pharmacological class: Erythropoiesis-stimulating agents (ESAs) | Indications: 1. Chronic kidney disease (CKD) 2. Cancer chemotherapy 3. HIV infection treatment with zidovudine |
